Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 32.26B | 28.63B | 14.80B | 29.03B | 5.31B | 13.22B |
Gross Profit | 6.39B | 5.29B | 5.53B | 9.69B | 866.03M | 4.12B |
EBITDA | 3.93B | 3.54B | 4.90B | 8.18B | -1.00B | 2.81B |
Net Income | 1.93B | 1.82B | 3.73B | 3.51B | -1.06B | 2.43B |
Balance Sheet | ||||||
Total Assets | 54.43B | 55.23B | 49.90B | 39.39B | 25.75B | 24.89B |
Cash, Cash Equivalents and Short-Term Investments | 6.48B | 16.39B | 8.73B | 5.70B | 2.16B | 4.34B |
Total Debt | 30.69B | 29.79B | 29.64B | 23.75B | 16.19B | 14.30B |
Total Liabilities | 37.25B | 36.68B | 34.12B | 28.46B | 17.13B | 5.36M |
Stockholders Equity | 17.18B | 18.55B | 15.79B | 10.93B | 7.59B | 8.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 6.72B | -3.36B | 19.23B | -3.76B | -8.93B |
Operating Cash Flow | 0.00 | 7.03B | -3.26B | 19.28B | -3.72B | -8.92B |
Investing Cash Flow | 0.00 | -457.44M | -314.78M | -4.59B | -315.54M | -1.98B |
Financing Cash Flow | 0.00 | -1.23B | 6.59B | -11.23B | 1.86B | 12.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥15.59B | 5.80 | 6.77% | 21.00% | 4.63% | ||
72 Outperform | ¥25.00B | 16.79 | 5.46% | 4.30% | -0.38% | -18.03% | |
68 Neutral | ¥15.11B | 30.88 | 2.86% | -4.73% | -51.89% | ||
67 Neutral | ¥712.50B | 10.83 | 7.42% | 3.37% | 7.74% | 16.12% | |
61 Neutral | ¥15.02B | 10.57 | 6.35% | -22.99% | -50.67% | ||
53 Neutral | ¥19.28B | 17.46 | 1.99% | -36.03% | -39.34% | ||
39 Underperform | ¥7.27B | ― | ― | -13.81% | 46.88% |